Neuroendocrine Tumours (NENs): New Treatments, Daraxonrasib & Why Genomic Testing Matters
What are NENs? Neuroendocrine neoplasms (NENs) are cancers that start in hormone‑producing (neuroendocrine) cells: there are 2 key classifications based on differentiation (how cells look and behave): Neuroendocrine Tumours are well-differentiated with a slow to...
Pamela L. Kunz, MD, on Pancreatic Neuroendocrine Tumors
ASCO News on CapTem chemotherapy trial Associate Professor Pamela L. Kunz*, MD, of the Yale University School of Medicine, discusses new findings from the ECOG-ACRIN E2211 trial (ClinicalTrials.gov Identifier: NCT01824875): Temozolomide With or Without Capecitabine in...